Can mesoporous nanoparticles promote bioavailability of topical pharmaceutics?

• Published in: International journal of pharmaceutics Vol. 602; p. 120609
• Main Authors: Valetti, Sabrina, Thomsen, Hanna, Wankar, Jitendra, Falkman, Peter, Manet, Ilse, Feiler, Adam, Ericson, Marica B., Engblom, Johan
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.06.2021
• Subjects: Chemical Sciences; Dermal drug delivery; drug-delivery; Kemi; microscopy; Multiphoton microscopy; Nanoparticles; oxide; particles; Pharmacology & Pharmacy; silica nanoparticles; skin penetration; Skin topography; Targeted delivery; Nanoparticles; Skin topography; Dermal drug delivery; Targeted delivery; Multiphoton microscopy
• ISSN: 0378-5173; 1873-3476; 1873-3476
• DOI: 10.1016/j.ijpharm.2021.120609

[Display omitted] When applied to skin, particulate matter has been shown to accumulate in hair follicles. In addition to follicles, the skin topography also incorporates trench-like furrows where particles potentially can accumulate; however, the furrows have not been as thoroughly investigated in a drug delivery perspective. Depending on body site, the combined follicle orifices cover up to 10% of the skin surface, while furrows can easily cover 20%, reaching depths exceeding 25 µm. Hence, porous particles of appropriate size and porosity could serve as carriers for drugs to be released in the follicles prior to local or systemic absorption. In this paper, we combine multiphoton microscopy, scanning electron microscopy, and Franz cell diffusion technology to investigate ex-vivo skin accumulation of mesoporous silica particles (average size of 400–600 nm, 2, and 7 µm, respectively), and the potential of which as vehicles for topical delivery of the broad-spectrum antibiotic metronidazole. We detected smaller particles (400–600 nm) in furrows at depths of about 25 µm, also after rinsing, while larger particles (7 µm) where located more superficially on the skin. This implies that appropriately sized porous particles may serve as valuable excipients in optimizing bioavailability of topical formulations. This work highlights the potential of skin furrows for topical drug delivery.